Abilify: Atypical Antipsychotic for Symptom Management and Stability
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.90 | $54.28 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $81.42 $70.37 (14%) | 🛒 Add to cart |
| 180 | $0.66 | $162.85 $118.62 (27%) | 🛒 Add to cart |
| 270 | $0.62 | $244.27 $166.87 (32%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $325.70 $215.12 (34%) | 🛒 Add to cart |
| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.54 | $46.24 (0%) | 🛒 Add to cart |
| 60 | $1.09 | $92.48 $65.34 (29%) | 🛒 Add to cart |
| 90 | $0.94 | $138.72 $84.44 (39%) | 🛒 Add to cart |
| 120 | $0.85 | $184.96 $102.53 (45%) | 🛒 Add to cart |
| 180 | $0.79 | $277.44 $141.74 (49%) | 🛒 Add to cart |
| 270 | $0.74 | $416.17 $199.04 (52%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $554.89 $254.32 (54%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.48 | $74.39 (0%) | 🛒 Add to cart |
| 60 | $1.76 | $148.77 $105.55 (29%) | 🛒 Add to cart |
| 90 | $1.52 | $223.16 $136.71 (39%) | 🛒 Add to cart |
| 120 | $1.39 | $297.55 $166.87 (44%) | 🛒 Add to cart |
| 180 | $1.27 | $446.32 $229.19 (49%) | 🛒 Add to cart |
| 270 | $1.20 | $669.49 $322.68 (52%) | 🛒 Add to cart |
| 360 | $1.15
Best per pill | $892.65 $415.16 (53%) | 🛒 Add to cart |
Synonyms | |||
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity, key neurotransmitters implicated in mood, perception, and behavior regulation. Clinicians value Abilify for its evidence-based role in reducing symptoms and supporting long-term functional recovery.
Features
- Active ingredient: Aripiprazole
- Available formulations: Oral tablets, orally disintegrating tablets, oral solution, and injectable forms
- Receptor activity: Partial agonist at D2 and 5-HT1A receptors; antagonist at 5-HT2A receptors
- FDA-approved for multiple indications including schizophrenia, bipolar I disorder, and adjunctive treatment of major depressive disorder
- Dosing flexibility across formulations and patient needs
Benefits
- Reduces positive and negative symptoms of schizophrenia, such as hallucinations and social withdrawal
- Helps stabilize mood episodes in bipolar I disorder, decreasing the frequency of manic or mixed episodes
- Enhances antidepressant effect when used adjunctively in treatment-resistant depression
- Generally associated with a lower risk of metabolic side effects compared to some other antipsychotics
- Supports improved daily functioning and quality of life through symptom control
- Offers multiple administration routes for individualized treatment plans
Common use
Abilify is commonly prescribed for the management of schizophrenia in adults and adolescents aged 13 years and older. It is also used for acute and maintenance treatment of bipolar I disorder, both as monotherapy and as part of combination therapy. Additionally, it is indicated as an adjunct to antidepressants for major depressive disorder in adults. Off-label uses may include irritability associated with autistic disorder in pediatric patients (though other formulations are specifically approved for this), and adjunctive treatment in other mood or anxiety disorders, under careful specialist supervision.
Dosage and direction
Dosage must be individualized based on indication, patient response, and tolerability. For schizophrenia in adults, the recommended starting dose is 10–15 mg once daily, which may be adjusted to a maximum of 30 mg daily. For bipolar mania, initial dosing is usually 15 mg once daily, with a range of 15–30 mg. As an adjunct for depression, the starting dose is 2–5 mg daily, with titration based on response and side effects. Abilify should be taken with or without food, at approximately the same time each day. Always follow the prescribing clinician’s instructions; do not adjust dosage without consultation.
Precautions
Patients should be monitored for worsening depression, suicidal thoughts, or unusual changes in behavior, especially at the beginning of treatment or during dosage adjustments. Use with caution in individuals with cardiovascular diseases, seizure disorders, or conditions that may predispose to hypotension. Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death; Abilify is not approved for this population. Regular assessments of weight, blood glucose, and lipid levels are recommended due to potential metabolic effects. Avoid abrupt discontinuation unless advised by a healthcare provider.
Contraindications
Abilify is contraindicated in patients with a known hypersensitivity to aripiprazole or any component of the formulation. Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole) or strong CYP2D6 inhibitors may require dosage adjustments; consult full prescribing information. Use is also contraindicated in conditions where central nervous system depression poses significant risk, or in patients with severe hepatic impairment, unless closely supervised.
Possible side effects
Common side effects may include nausea, vomiting, constipation, headache, dizziness, insomnia, akathisia, and sedation. Weight gain, although generally modest, may occur. Extrapyramidal symptoms such as tremor or muscle stiffness are possible but less frequent than with typical antipsychotics. Rare but serious side effects include neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, and orthostatic hypotension. Patients should report any persistent or severe symptoms to their healthcare provider promptly.
Drug interaction
Abilify is primarily metabolized by CYP3A4 and CYP2D6 enzymes. Concomitant use with strong inhibitors of these enzymes (e.g., fluoxetine, quinidine, ketoconazole) may increase aripiprazole concentrations, while inducers (e.g., carbamazepine) may decrease levels. Use with other central nervous system depressants, including alcohol, benzodiazepines, or opioids, may enhance sedative effects. Caution is advised when combining with antihypertensive agents due to potential additive hypotension. Always inform your prescriber of all medications, supplements, and herbal products you are taking.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is close to the time of the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up. Consistent daily administration is important for maintaining therapeutic levels; consider setting a reminder or using a pill organizer if forgetting doses is a recurring issue.
Overdose
In cases of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include sedation, tachycardia, nausea, vomiting, and hypotension. General supportive measures should be employed, with attention to maintaining airway and vital signs. There is no specific antidote for aripiprazole overdose; management is symptomatic and supportive. ECG monitoring may be advisable due to potential effects on cardiac conduction.
Storage
Store Abilify tablets and oral solution at room temperature (15–30°C or 59–86°F), in a tightly closed container, and protect from light and moisture. Keep the oral solution from freezing. Do not use beyond the expiration date printed on the packaging. Keep all medications out of reach of children and pets. Dispose of unused medication properly, following local guidelines or through a drug take-back program.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read in this product card. Individual patient needs and responses to treatment may vary.
Reviews
Clinical trials and post-marketing studies generally support the efficacy and tolerability of Abilify for its approved indications. Many patients report significant improvement in symptom control and daily functioning. However, experiences can vary; some individuals may not respond adequately or may experience side effects that affect adherence. Long-term treatment success often depends on regular follow-up, open communication with healthcare providers, and a comprehensive treatment approach that may include therapy and lifestyle support. Always discuss your personal experience and any concerns with your prescribing clinician.